Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinico-pathological parameters
This study found increased cyclooxygenase-2 expression in the ovarian endometriotic cyst wall compared to other sites, but no correlation with clinico-pathological parameters or patient symptoms.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (24)
- Classification of endometriotic implants by morphologic appearance and capacity to synthesize prostaglandin F via openalex
- Comparative immunohistochemical studies of endometriosis lesions and endometriotic cysts via openalex
- Deep endometriosis conundrum: evidence in favor of a peritoneal origin via openalex
- Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis via openalex
- Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities via openalex
- Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis via openalex
- Peritoneal fluid prostaglandins in various stages of the menstrual cycle: role in infertile patients with endometriosis. via openalex
- Peritoneal fluid thromboxane B2 and 6-keto-prostaglandin F1α in endometriosis via openalex
- The aetiology of endometriosis via openalex
- Treating endometriosis as an autoimmune disease via openalex
- W2043707891 via openalex
- W2110844151 via openalex
- W2039274017 via openalex
- W2127558096 via openalex
- W2029790299 via openalex
- W2146708145 via openalex
- W2019881493 via openalex
- W2238870413 via openalex
- W2346704459 via openalex
- W1966927722 via openalex
- W1865550052 via openalex
- W2097865940 via openalex
- W2477008945 via openalex
- W2109322259 via openalex
Cited by (48)
- Pathophysiology of Endometriosis: Insights from Immunohistochemical Analysis of Ectopic and Eutopic Tissues 2025
- Progressively Diminished Prostaglandin E2 Signaling in Concordance with Increasing Fibrosis in Ectopic Endometrium 2024
- Hypoxia-hindered methylation of PTGIS in endometrial stromal cells accelerates endometriosis progression by inducing CD16- NK-cell differentiation 2022
- Endometriosis Research: From Bench to Bedside 2022
- Changing prostaglandin E2 (PGE<sub>2</sub>) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE<sub>2</sub> receptor EP2 and EP4 2021
- Higher fibrotic content of endometriotic lesions is associated with diminished prostaglandin E2 signaling 2021
- Peritoneal Fluid Cytokines Reveal New Insights of Endometriosis Subphenotypes 2020
- Molecular Mechanisms Underlying Adolescent Endometriosis and Advancements in Medical Management 2020
- Synchronous primary endometrial and ovarian cancers: how to diagnose, differentiate and treat in the light of recent available literature data 2020
- Reduced inflammatory state promotes reinnervation of endometriotic-like lesions in TNFRp55 deficient mice 2019
- Comparing The Effects of Glycyrrhiza glabra Root Extract, A Cyclooxygenase-2 Inhibitor (Celecoxib) and A Gonadotropin-Releasing Hormone Analog (Diphereline) in A Rat Model of Endometriosis. 2019
- Bioinformatics strategy for the screening of key genes to differentiate adenomyosis from endometriosis (Review) 2019
- Predictive factors of ovarian endometrioma recurrence after laparoscopic excision: risk factors and prevention 2018
- Immunohistochemical predictors of recurrent ovarian endometriomas after laparoscopic surgery 2018
- The promising role of placental growth factor in association with cyclooxygenase-2 as predictive markers for recurrent ovarian endometriosis 2017
- Prostaglandin F2a–PTGFR signalling activation, growth factor expression and cell proliferation in bovine endometrial explants 2017
- Regulation of Matrix Metalloproteinase-2 Activity by COX-2-PGE2-pAKT Axis Promotes Angiogenesis in Endometriosis 2016
- COX-2 gene promoter DNA methylation status in eutopic and ectopic endometrium of Egyptian women with endometriosis 2015
- Platelets are an unindicted culprit in the development of endometriosis: clinical and experimental evidence 2015
- Genetic variation in COX-2 -1195 and the risk of endometriosis and adenomyosis 2015
- Effects of Hominis Placenta Pharmacopuncture Therapy on the Experimentally-induced Endometriosis in the Rats 2014
- Role of Nerve Fibres in Endometriosis 2014
- Hormonal Therapy Deregulates Prostaglandin-Endoperoxidase Synthase 2 (<i>PTGS2</i>) Expression in Endometriotic Tissues 2013
- Anastrozole and celecoxib for endometriosis treatment, good to keep them apart? 2012
- Implication of the RAGE–EN‐RAGE axis in endometriosis 2010
- The inducible prostaglandin E synthase mPGES-1 regulates growth of endometrial tissues and angiogenesis in a mouse implantation model 2010
- Expression of Cyclooxygenase-2 in Eutopic Endometrium and Ovarian Endometriotic Tissue in Women with Severe Endometriosis 2009
- Cyclooxygenase-2 expression, Ki-67 labeling index, and perifocal neovascularization in endometriotic lesions 2009
- Involvement of iron, nuclear factor-kappa B (NF-KB) and prostaglandins in the pathogenesis of peritoneal endometriosis-associated inflammation: A review 2009
- Involvement of Iron, Nuclear Factor-Kappa B (NF-κB) and Prostaglandins in the Pathogenesis of Peritoneal Endometriosis-Associated Inflammation: A Review 2009
- Cyclooxygenase-2 overexpression in ovarian endometriomas is associated with higher risk of recurrence 2008
- Emerging drugs for endometriosis 2008
- Angiogenesis and antiangiogenic therapy in endometriosis 2007
- Selective Estrogen-Receptor Modulators and Aromatase Inhibitors: Promising New Medical Therapies for Endometriosis? 2007
- Regression of endometrial explants in a rat model of endometriosis treated with melatonin 2007
- Interleukin (IL)-17A Stimulates IL-8 Secretion, Cyclooxygensase-2 Expression, and Cell Proliferation of Endometriotic Stromal Cells 2007
- Suppression of IL-1β-induced COX-2 expression by trichostatin A (TSA) in human endometrial stromal cells 2007
- Der derzeitige Stand der konservativen Therapie der Endometriose 2006
- A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice 2006
- Effects of Yiweining Recipe on expressions of metalloproteinase-2 and cyclooxygenase-2 mRNAs in ectopic endometrium of rats with endometriosis 2006
- Endometriosis: Current thinking 2006
- Increased cyclooxygenase-2 expression is associated with better clinical outcome in patients submitted to complete ablation for severe endometriosis 2005
- Endometriosi e cancro 2005
- COX-2 overexpression in peritoneal lesions is correlated with nonmenstrual chronic pelvic pain 2005
- Endometriosis: Current thinking 2005
- Aromatase inhibitors and cyclooxygenase-2 (COX-2) inhibitors in endometriosis: New questions—old answers? 2005
- Aromataseinhibitoren bei Endometriose? 2004
- Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis 2004
Source provenance
- europepmc
- last seen: 2026-08-28T06:11:01.063540+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:12:38.158000+00:00